| Breakdown | TTM | Nov 2025 | Nov 2024 | Nov 2023 | Nov 2022 | Nov 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 24.45B | 23.77B | 21.50B | 19.41B | 17.61B | 15.79B |
| Gross Profit | 21.79B | 21.06B | 19.15B | 17.05B | 15.44B | 13.92B |
| EBITDA | 9.88B | 9.75B | 7.96B | 7.78B | 7.05B | 6.67B |
| Net Income | 7.21B | 7.13B | 5.56B | 5.43B | 4.76B | 4.82B |
Balance Sheet | ||||||
| Total Assets | 29.70B | 29.50B | 30.23B | 29.78B | 27.16B | 27.24B |
| Cash, Cash Equivalents and Short-Term Investments | 6.89B | 6.59B | 7.89B | 7.84B | 6.10B | 5.80B |
| Total Debt | 6.66B | 6.65B | 6.06B | 4.08B | 4.63B | 4.67B |
| Total Liabilities | 18.27B | 17.87B | 16.13B | 13.26B | 13.11B | 12.44B |
| Stockholders Equity | 11.43B | 11.62B | 14.11B | 16.52B | 14.05B | 14.80B |
Cash Flow | ||||||
| Free Cash Flow | 10.32B | 9.85B | 7.82B | 6.94B | 7.40B | 6.89B |
| Operating Cash Flow | 10.51B | 10.03B | 8.06B | 7.30B | 7.84B | 7.22B |
| Investing Cash Flow | -229.00M | -1.19B | 149.00M | 776.00M | -570.00M | -3.54B |
| Financing Cash Flow | -10.76B | -11.06B | -7.72B | -5.18B | -6.83B | -4.30B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | $96.73B | 14.24 | 62.31% | ― | 10.53% | 34.24% | |
74 Outperform | $2.78T | 23.36 | 33.61% | 0.71% | 16.67% | 28.60% | |
67 Neutral | $50.78B | 47.92 | 39.89% | ― | 15.62% | 2.59% | |
66 Neutral | $78.57B | 287.80 | 4.57% | ― | 12.62% | -45.12% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
56 Neutral | $9.63B | -46.16 | -12.57% | ― | -8.23% | 48.57% | |
56 Neutral | $10.51B | -15.27 | -92.27% | ― | ― | ― |